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We aimed to investigate the association between the time to positivity of blood culture (TTP)
with clinical outcome and severity of pneumococcal bacteremic pneumonia.
Methods
Prospective observational study carried out in 278 hospitalized adult CAP patients with posi-
tive blood culture for Streptococcus pneumonia (2003–2015).
Results
A total of 278 cases of bacteremic pneumococcal pneumonia were analyzed, median age
62 (46; 79) years. Fifty-one percent of the cases had PSI IV-V. Twenty-one (8%) died within
30-days after admission. The analysis of the TTP showed that the first quartile of the TTP
(9.2h) was the best cut-off for differentiating 2 groups of patients at risk, early (TTP <9.2 h)
and late (TTP9.2 h) detection groups (AUC 0.66 [95% CI 0.53 to 0.79]). Early TTP was
associated with a statistically significant risk of invasive mechanical ventilation (18% vs. 6%,
p = 0.007), longer length of hospital stay (12 days vs. 8 days, p<0.001), higher in-hospital
mortality (15% vs. 4%, p = 0.010), and 30-day mortality (15% vs. 5%, p = 0.018). After
adjustment for potential confounders, regression analyses revealed early TTP as indepen-
dently associated with high risk of invasive mechanical ventilation (OR 4.60, 95% CI 1.63 to
13.03), longer length of hospital stay (β 5.20, 95% CI 1.81 to 8.52), higher in-hospital mortal-
ity (OR 5.35, 95% CI 1.55 to 18.53), and a trend to higher 30-day mortality (OR 2.47, 95% CI
0.85 to 7.21) to be a contributing factor.
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Conclusion
Our results demonstrate that TTP is an easy to obtain surrogate marker of the severity of
pneumococcal pneumonia and a good predictor of its outcome.
Introduction
Streptococcus pneumoniae remains the most frequent cause of community-acquired pneumonia
(CAP) [1,2]. Bacteremia is documented in 25% of cases [3] and their mortality is 15% to 26%
greater than in non-bacteremic patients [4]. The identification of early predictors of worse out-
come in patients with bacteremic CAP due to S. pneumoniae is therefore of utmost importance.
There is evidence about the association between the high bacterial load and worse clinical out-
comes in invasive pneumococcal pneumonia [5,6]. This evidence suggests that determination of
pneumococcal load has a clinical utility. Some previous studies suggest that time to positivity
(TTP) of blood culture may provide early clues about microorganisms involved and the source
of bacteremia [7]. Also, TTP is inversely associated with blood bacterial load (8) and is therefore
a reasonable marker of more severe disease and a potential early predictor of mortality.
Two previous studies analyzed the TTP in children and adults with S. pneumoniae bacter-
emia [8,9]. The experience in children included 175 episodes from different sources (meni-
ngitis, pneumonia) and no association was found between TTP and clinical or laboratory
parameters except that of the 150 patients seen in the emergency department, those in the first
decile were significantly more likely to be admitted to the hospital than were patients in the
10th decile (10 of 15 patients [67%] vs. 5 of 16 patients [31%]; p = 0.02) [9]. In contrast, the
experience in adults included 105 episodes and shorter TTP was associated with immunosup-
pression, severe sepsis and shock, meningitis or ICU admission [8]. However, the number of
patients with CAP included in these studies was low and the authors did not evaluate the
potential relationship with mortality.
S. pneumoniae is capable of producing a different phenotypic expression, depending on the
capsular serotype; it is known that certain serotypes can cause a more invasive disease than
others [3]. The higher virulence of these serotypes could be associated with a shorter TTP.
The aim of our study was to evaluate the TTP in prospectively collected episodes of bacter-
emic CAP due to S. pneumoniae from 2003 to 2015 and to correlate the TTP with the severity
of CAP, the S. pneumoniae serotype and the length of hospital stay, in-hospital mortality rate,




The study was approved by the Ethics Committee of Hospital Clinic of Barcelona, Spain (Reg-
ister: 2009/5451). Written informed consent was waived due to the non-interventional design.
Patients’ identification remained anonymous.
Study design and patients
We performed a prospective observational study including all adults consecutively admitted
between 2003 to 2015 with a diagnosis of community-acquired pneumococcal pneumonia to
the Hospital Clinic of Barcelona, Spain, an 800-bed third-level hospital covering an urban
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population of 540,000 inhabitants. We excluded patients who were immunosuppressed,
receiving immunosuppressant (those taking>10 mg/day of prednisone or cytotoxic therapy)
and all patients known to have human immunodeficiency virus infection.
Data collection and evaluation
At the initial visit, patients underwent a complete clinical history and physical examination.
Patients were stratified into risk classes using the validated prediction rule calculated according
to the Pneumonia Severity Index (PSI) score [10]. We also calculated the CURB-65 [11] and
the sequential organ failure assessment (SOFA) [12] scores at admission. Empirical antibiotic
treatment was administered according to the Infectious Disease Society of America/American
Thoracic Society (IDSA/ATS) guidelines for management of CAP [13]. All surviving patients
were visited at 30–40 days after discharge.
Microbiological evaluation and diagnostic criteria
Regular sampling included sputum specimens, two blood cultures, urine samples for detection
of S. pneumoniae (BinaxNOW S. pneumoniae Urinary Antigen Test; Emergo Europe, The
Hague, The Netherlands) and Legionella pneumophila serogroup 1 (BinaxNOW L. pneumo-
phila Urinary Antigen Test; Trinity Biotech, Bray, Ireland). Samples from pleural fluid punc-
ture, tracheobronchial aspiration (TBAS) and blind bronchoalveolar lavage (BAL) were
obtained according to the judgment of the attending physician.
The etiology of pneumococcal pneumonia was determined in cases with a positive valid
sputum culture, positive blood culture; positive pleural fluid and transthoracic needle aspira-
tion cultures; positive urinary antigen for S. pneumoniae; bacterial growth in cultures of TBAS
105 CFU/ml, in Protective Brush Sample (PBS)103 CFU/ml, and in BAL104 CFU/ml.
For the purpose of this study we only included patients with positive blood culture.
Blood cultures were processed by the BACTEC 9240 system (Becton-Dickinson, MD,
USA), and vials were loaded into the machine around the clock. Volumes between 8 to 10 ml
of blood samples were inoculated into aerobic and anaerobic vials. The vials used were the
resin-containing BACTEC Plus Aerobic/F and BACTEC Plus Anaerobic/F or the non-resin-
containing BACTEC Standard 10 Aerobic/F and BACTEC Lytic/10 Anaerobic/F. The incuba-
tion period was 5 days before being discarded as negative. The identification of microorgan-
isms isolated from positive cultures was performed according to conventional methods.
Strains were initially screened for antimicrobial susceptibility using Sensititre (Trek Diag-
nostic Systems Ltd, West Sussex, England). Penicillin and other antibiotic susceptibilities were
defined according to EUCAST criteria [14]. For S. pneumoniae isolates, minimum inhibitory
concentrations (MICs) were determined using the Sensititre for penicillin, cefotaxime, ceftri-
axone, cefepime, imipenem, meropenem, erythromycin, clindamycin, levofloxacin, and van-
comycin. Results were interpreted according to EUCAST criteria [14].
Pneumococcal isolates were identified by standard microbiological methods. All strains iso-
lated from normally sterile sites were routinely frozen at -70˚C in skimmed milk until serotype
detection was performed. Isolates were serotyped at the Spanish Reference Laboratory for
Pneumococci (Majadahonda, Madrid, Spain) by using the Quellung reaction (antisera pro-
vided by the Statens Serum Institute Copenhagen, Denmark) and/or dot blot analysis [15].
Definitions
Pneumonia was defined as the presence of a new infiltrate on a chest radiograph together with
clinical symptoms that were suggestive of lower respiratory tract infection (e.g., fever, cough,
sputum production, pleuritic chest pain).
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Prior antibiotic treatment was considered when antibiotics had been taken in the previous
month.
Bacteremic pneumococcal pneumonia was defined as the presence of a positive blood cul-
ture for S. pneumoniae.
The TTP was determined from the time interval between the start of incubation and the
detection of microbial growth in peripheral blood, as documented using an automated moni-
toring system. When multiple cultures were positive only the shortest TTP was selected for
analysis.
Pneumococcal serotypes were grouped according to the invasive potential: low (serotypes
3, 6A, 6B, 19A, 19F AND 23F), medium (4, 9N, 9V, 14 and 18C) and high (1, 5 and 7F) [16–
18].
Severe CAP was defined according to the IDSA/ATS guidelines criteria [13].
Pulmonary complications were defined by the presence of pleural effusion, empyema, or
multilobar infiltrates. Extra-pulmonary complication was defined by the presence of septic
shock and acute renal failure.
Clinical outcomes
The primary outcome was in-hospital mortality. Secondary outcomes included length of hos-
pital stay, 30-day mortality, ICU admission, length of stay in ICU, ICU mortality, and need of
mechanical ventilation.
Statistical analysis
Data are shown as number and percentage of patients for categorical variables and median
(Quartile 1 [Q1]; Quartile 3 [Q3]) for continuous variables with non-normal distribution or
mean (standard deviation [SD]) for those with normal distribution. Categorical variables were
compared using the X2 test or the Fisher exact test. Continuous variables were compared using
the t-test or the nonparametric Mann-Whitney test. A receiver operating characteristic (ROC)
curve was constructed to determine the best cut-point for TTP to predict in-hospital mortality.
Youden’s index [19] was defined for all points along the ROC curve, and the maximum value
of the index was used as a criterion for selecting the optimum cut-off point. Regression analy-
ses [20,21] were used to examine the associations between outcomes (a linear regression analy-
sis for length of hospital stay, two logistic regression analyses for in-hospital mortality and
30-day mortality, and a multinomial logistic regression analysis for non-invasive or invasive
mechanical ventilation) and risk factors. In a first step, each risk factor was tested individually.
In a second step, all risk factors which showed an association in the univariate model (p<0.10)
were added into the multivariate model. Finally, a backward stepwise selection (pin<0.05,
pout<0.10) was used to determine factors associated with outcome. The beta coefficient (β)
and 95% confidence interval (CI) and the odds ratio (OR) and 95% (CI) were calculated where
applicable. The Hosmer-Lemeshow goodness-of-fit test was performed to assess the overall fit
of the logistic regression models, the R2 for the linear regression model, and the Cox and Snell
R2 and the Nagelkerke R2 for the multinomial logistic regression model. Internal validation of
the prediction models was conducted using ordinary nonparametric bootstrapping with 1,000
bootstrap samples and bias-corrected, accelerated 95% CIs [22]. The area under the ROC
curve of the multivariate models to predict in-hospital mortality, 30-day mortality, non-inva-
sive and invasive mechanical ventilation were calculated. Simple imputations of random effects
were used, if necessary, for variables with missing values. The level of significance was set at
0.05 (2-tailed). All analyses were performed using IBM SPSS Statistics version 22.0 (Armonk,
New York, USA).
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Results
Participants
During the study period, 4,639 patients were admitted in the Emergency Department with the
diagnosis of CAP. Blood cultures were performed on 3,274 (71%) and were positive in 419
(13%). Of these, 301 (72%) were positive for S. pneumoniae, and 23 were excluded from the
analysis due to missing TTP, to having human immunodeficiency virus infection and/or who
were receiving immunosuppressant. Therefore, 278 cases were finally included in the study.
Fig 1 shows the flow diagram of the study population.
General characteristics of the study population
The median (Q1; Q3) age was 62 (46; 79) years (152 patients [55%] aged <65 yrs) and 165
(59%) of the patients were male. On admission, 142 patients (51%) were classified in the high-
Fig 1. Flow diagram of the selected population.
https://doi.org/10.1371/journal.pone.0182436.g001
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risk group of PSI score (IV-V). Thirty-four patients (13%) received prior antibiotic treatment
and 25 (10%) had prior pneumococcal vaccination. Severe CAP, according to the ATS/IDSA
criteria, was present in 82 patients (38%), pulmonary complications in 127 (47%), and extra
pulmonary complication in 111 (41%) (Septic shock 30; 11% and acute renal failure 103, 38%).
Eighty-seven patients (31%) were admitted to the ICU and 43 (17%) needed mechanical venti-
lation. Twenty-one patients (8%) died within 30 days after admission. Out of 278 isolates, 186
(67%) were available for serotyping (period 2006–2015). The most frequent serotypes in this
population were 1 (n = 36, 19%), 3 (n = 20, 11%), 19A (n = 19, 10%), 7F (n = 16, 9%), and 14
(n = 11, 6%).
Minimal inhibitory concentration (MIC) testing was performed in 272 out of 278 S. pneu-
moniae isolates (98%). A total of 220 pneumococcal isolates (81%) were penicillin susceptible
(MIC 0.06 mg/L); while 26 (10%) were intermediate (MIC 0.12–2 mg/L) and 26 (10%) were
resistant (MIC > 2 mg/L). In addition, 41 pneumococcal isolates (15%) were non-susceptible
to erythromycin, (MIC1 mg/L).
Time to positivity of S. Pneumoniae
The median TTP of S. pneumoniae in blood culture among the 278 adult patients with pneu-
mococcal CAP was 10.5 (9.2; 11.5) hours (Fig 2). Following Youden’s index methodology, we
Fig 2. Time to positivity of S. Pneumoniae in blood culture.
https://doi.org/10.1371/journal.pone.0182436.g002
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selected 9.2 h as the optimal cut-off point for TTP in relation to in-hospital mortality (Fig 3)
(53% sensitivity, 77% specificity, 14% positive predictive value, 96% negative predictive value,
2.31 positive likelihood ratio, and 0.61 negative likelihood ratio). Patients were divided into
two detection groups: early detection group (TTP <9.2 h: 69 patients [25%]) and late detection
group (TTP9.2 h: 209 patients [75%]).
Table 1 summarizes the main characteristics of the 278 patients.
Comparison of characteristics of early and late detection pneumonia
Baseline characteristics comparing cases on early detection group and late detection group
appear in Table 1.
We found non-significant differences in the use of previous antibiotics and pneumococcal
vaccine between groups. Compared with the late group, cases in the early detection group pre-
sented fever at admission less frequently, more days of symptoms, low white blood cell count,
low lymphocyte count, higher serum levels of C-reactive protein, and worse oxygenation at
admission. Also, the early detection group presented a higher median PSI score, more severe
CAP according to the IDSA/ATS definition, and more pulmonary complications.
Fig 3. Receiver operating characteristic curve for time to positivity of S. pneumoniae to predict in-
hospital mortality.
https://doi.org/10.1371/journal.pone.0182436.g003
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Table 1. Baseline characteristics of study cohort.
Variables Cohort of patients Early detection <9.2 h Late detection
9.2 h
P Value
n = 278 n = 69 n = 209
Age, median (IQR), years 62 (46; 79) 67 (50; 81) 60 (46; 75) 0.063
Male sex, n (%) 165 (59) 39 (57) 126 (60) 0.58
Current smoker, n (%) 93 (34) 19 (30) 74 (36) 0.35
Current alcohol abuse, n (%) 51 (19) 10 (15) 41 (20) 0.19
Previous antibiotic, n (%) 34 (13) 6 (9) 28 (14) 0.32
Influenza vaccine, n (%) 74 (31) 15 (27) 59 (32) 0.53
Pneumococcal vaccine, n (%) 25 (10) 7 (13) 18 (10) 0.53
Inhaled corticosteroid, n (%) 36 (13) 9 (13) 27 (13) 0.94
Systemic corticosteroid, n (%) 11 (4) 3 (4) 8 (4) 0.84
Comorbidity, n (%)a 163 (59) 37 (54) 126 (60) 0.33
Chronic respiratory disease 97 (36) 20 (30) 77 (38) 0.23
Chronic cardiovascular disease 23 (8) 7 (10) 16 (8) 0.50
Diabetes mellitus 48 (18) 13 (19) 35 (17) 0.65
Neurological disease 41 (16) 10 (15) 31 (16) 0.93
Chronic renal disease 18 (7) 4 (6) 14 (7) 0.79
Chronic liver disease 22 (8) 3 (4) 19 (2) 0.20
Clinical presentation
Days of symptoms, median (IQR) 4 (3; 7) 4 (3; 7) 4 (2; 6) 0.030
Dyspnoea 183 (67) 49 (73) 134 (76) 0.25
Pleural pain 154 (57) 37 (58) 117 (57) 0.91
Fever 238 (87) 53 (79) 185 (89) 0.031
Laboratory findings, n (%)
Creatinine1.5 mg/dL 97 (35) 26 (38) 71 (35) 0.62
C-reactive protein15 mg/dL 210 (80) 62 (91) 148 (76) 0.008
White blood cell count10 × 109/L 193 (70) 36 (52) 157 (76) 0.001
Lymphocytes count 109/L, median (IQR) 750 (415; 1,188) 486 (244; 1,224) 792 (480; 1,188) 0.016
PaO2/FIO2 ratio <250 73 (39) 25 (54) 48 (34) 0.013
SOFA score, median (IQR) 3 (1; 4) 3 (2; 4) 2 (1; 4) 0.093
PSI score, median (IQR) 92 (66; 118) 101 (76; 124.5) 87 (65; 115) 0.031
PSI risk class, n (%)b 0.031
I-III 136 (49) 26 (38) 110 (53)
IV-V 142 (51) 43 (62) 99 (47)
CURB-65, n (%) 0.70
0–2 218 (83) 55 (81) 163 (83)
3–5 46 (17) 13 (19) 33 (17)
Severe CAP, n (%) 82 (38) 29 (52) 53 (33) 0.011
Pulmonary complications, n (%)c 127 (47) 40 (60) 87 (42) 0.014
Pleural efusion 50 (18) 18 (27) 32 (16) 0.039
Multilobar infiltration 93 (34) 29 (42) 64 (31) 0.082
ARDS 18 (7) 6 (9) 12 (6) 0.37
Extra-pulmonary complications, n (%)d 111 (41) 29 (43) 82 (40) 0.61
Acute renal failure 103 (38) 28 (41) 75 (37) 0.49
Septic shock 30 (11) 9 (13) 21 (10) 0.45
Empiric antibiotic therapy, n (%)
ß-lactam plus fluroroquinolone 109 (39) 37 (54) 72 (35) 0.007
(Continued)
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Outcomes
The early detection group had a longer length of hospital stay, higher rate of in-hospital mor-
tality, higher rate of 30-day mortality, and higher rate of invasive mechanical ventilation com-
pared to the longer detection group (Table 2).
Of the 21 patients who died at 30 days, approximately half were in the early detection group
(10 of 21 cases [48%])
We found no difference between groups in ICU admission, length of ICU stay or ICU
mortality.
We added early detection (TTP <9.2 h) to the CURB-65 and PSI scores to predict mortal-
ity, and the effectiveness of the new scores was compared. The addition of early TTP improved
Table 1. (Continued)
Variables Cohort of patients Early detection <9.2 h Late detection
9.2 h
P Value
n = 278 n = 69 n = 209
ß-lactam plus macrolide 90 (33) 19 (28) 71 (34) 0.34
Fluoroquinolone monotherapy 44 (20) 7 (10) 37 (18) 0.18
Appropriate empiric treatment, n (%) 190 (93) 54 (98) 136 (91) 0.083
Strain Penicillin resistant, n (%) 26 (10) 8 (12) 18 (9) 0.73
Strain Erithromycin resistant, n (%) 41 (15) 13 (19) 28 (14) 0.28
Abbreviations: ARDS = acute respiratory distress syndrome; CAP = community acquired pneumonia; CURB-65 = Consciousness, Urea, Respiratory rate,
Blood pressure, 65 years old; IQR = interquartile range; PaO2/FIO2 = arterial oxygen tension to inspired oxygen fraction ratio; PSI = pneumonia severity
index; SOFA = sequential organ failure assessment. Percentages calculated on non-missing data.
a Could have more than 1 comorbid condition.
b Stratified according to 30-day risk mortality for community-acquired pneumonia: risk classes I-III (90 points) have low mortality (range, 0%-10%) and risk
classes IV-V (>90 points) have the highest mortality (range, 10%-35%).
c Could have more than 1 pulmonary complication.
d Could have more than 1 extra-pulmonary complication.
https://doi.org/10.1371/journal.pone.0182436.t001
Table 2. Clinical outcomes.





n = 278 n = 69 n = 209
Length of hospital stay (days), median (IQR) 9 (5; 14) 12 (8; 18) 8 (5; 12) <0.001
Length of hospital stay,9 days, n (%) 139 (52) 47 (71) 92 (46) <0.001
In-hospital mortality, n (%) 19 (7) 10 (15) 9 (4) 0.010
30-day mortality, n (%) 21 (8) 10 (15) 11 (5) 0.018
ICU admission, n (%) 87 (31) 27 (39) 60 (29) 0.60
Length of ICU stay (days), mean (IQR) 5 (3; 9) 5.5 (4; 21.5) 5 (3; 7) 0.16
ICU mortality, n (%)a 8 (9) 4 (15) 4 (7) 0.24
Mechanical ventilation, n (%) 0.018
Not ventilated 216 (83) 44 (70) 172 (88) 0.029
Non-invasive 21 (8) 8 (13) 13 (7) 0.82
Invasive 22 (8) 11 (18) 11 (6) 0.007
Abbreviations: ICU = intensive care unit; IQR = interquartile range. Percentages calculated on non-missing data.
a 87 patients in the overall cohort, 27 patients in the early detection group and 60 patients in the late detection group were used to calculate the percentages.
https://doi.org/10.1371/journal.pone.0182436.t002
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the area under the ROC curves of the CURB-65 (0.84, 95% CI 0.74 to 0.95) and PSI (0.83, 95%
CI 0.76 to 0.90) but not reaching significance (Figs 4 and 5).
Predictors of length of hospital stay
The simple linear regression analysis revealed several variables significantly associated with
length of hospital stay (Table 3). The variables PCR15 mg/dl, PSI IV-V, ARDS and early
detection (TTP <9.2 h) were those independently associated with length of hospital stay in the
multiple analysis.
Internal validation of the linear regression model was conducted using bootstrapping with
1,000 samples. The three variables included in the model demonstrated robust results, with
small 95% CIs around the original coefficients.
Predictors of in-hospital mortality
The univariate logistic regression analysis revealed several variables significantly associated
with in-hospital mortality (Table 4). Among these variables, age65 years, acute renal failure,
Fig 4. Receiver operating characteristic curve for CURB-65 and modified CURB-65 to predict in-hospital mortality.
https://doi.org/10.1371/journal.pone.0182436.g004
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septic shock, ARDS, and early detection (TTP<9.2 h) were the variables independently associ-
ated with in-hospital mortality in the multivariate analysis.
The area under the ROC curve was 0.91 (95% CI 0.85 to 0.98) for the model predictive of
in-hospital mortality. Internal validation of the logistic regression model using bootstrapping
with 1,000 samples demonstrated robust results for the five variables included in the model,
with small 95% CIs around the original coefficients.
Predictors of 30-day mortality
The univariate logistic regression analysis revealed several variables significantly associated
with 30-day mortality (Table 5). The variables, PSI IV-V, ARDS, acute renal failure, and septic
shock were those independently associated with 30-day mortality. There was a trend for early
detection (TTP <9.2 h) to be a contributing factor for 30-day mortality.
The area under the ROC curve was 0.88 (95% CI 0.79 to 0.96) for the model predictive of
30-day mortality. Internal validation of the logistic regression model using bootstrapping with
1,000 samples demonstrated robust results for three of four variables included in the model,
Fig 5. Receiver operating characteristic curve for PSI and modified PSI to predict in-hospital mortality.
https://doi.org/10.1371/journal.pone.0182436.g005
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with small 95% CIs around the original coefficients, while the PSI appeared to be less reliable,
with a wider 95% CI around the original coefficient.
Predictors of the need for non-invasive or invasive mechanical
ventilation
The following risk factors showed significant associations with mechanical ventilation groups
in individual multinomial logistic regression and were thus used for the initial multivariate
model: alcohol consumption, chronic respiratory disease, lymphocytes, PSI risk class, ARDS,
and septic shock and early detection time. Results of the multivariate model are displayed in
Table 6. For non-invasive mechanical ventilation, the model shows the OR to be significantly
increased if they have prior alcohol consumption, PSI risk class IV-V, and septic shock. The
OR for invasive mechanical ventilation, however, was strongly increased with septic shock and
early detection (TTP <9.2 h). The area under the ROC curve was 0.75 (95% CI 0.65 to 0.84)
for the model predictive of non-invasive mechanical ventilation, and 0.81 (95% CI 0.70 to
0.91) for the model predictive of invasive mechanical ventilation.
Internal validation of the multinomial logistic regression model using bootstrapping with
1,000 samples demonstrated robust results for the four variables included in the model, with
small 95% CIs around the original coefficients.
Relationship between time to positivity and pneumococcal serotypes
In order to analyze the association between pneumococcal serotypes and time to positivity,
pneumococcal serotypes were divided into three groups according to invasiveness: low (sero-
types 3, 6A, 6B, 19A, 19F and 23F), intermediate (4, 9N, 9V, 14 and 18C) or high (1, 5 and 7F).
We did not find any association between TTP and serotype (early detection group (TTP <9.2
h): low 30%, intermediate 19%, high 51% vs. late detection group (TTP9.2 h): low 35%,
intermediate 22%, high 43%, p = 0.67).
Table 3. Significant simple and multiple linear regression analyses to predict length of hospital stay.
Variable Simple Multipleab
β 95% CI P Value β 95% CI P Value
Chronic respiratory disease 2.74 -0.45 to 5.93 0.092 - - -
C-reactive protein15 mg/dL 1.68 0.92 to 3.06 0.090 - - -
PSI risk class IV-V 4.67 1.62 to 7.72 0.003 3.97 1.14 to 6.81 0.006
Pleural effusion 3.74 -0.21 to 7.69 0.064 - - -
ARDS 16.42 10.7 to 22.1 <0.001 15.58 10.1 to 21.0 <0.001
Acute renal failure 4.18 1.02 to 7.35 0.010 - - -
Septic shock 5.96 1.03 to 10.9 0.018 - - -
Mechanical ventilation 8.40 5.98 to 10.8 <0.001 - - -
Early detection (time to positivity <9.2 h) 6.74 3.24 to 10.24 <0.001 5.20 1.81 to 8.52 0.002
Abbreviations: β = unstandardized beta coefficient; ARDS = acute respiratory distress syndrome; CI = confidence interval; OR = odds ratio;
PSI = pneumonia severity index.
Data are shown as estimated βs (95% CIs) of the explanatory variables in the model. Regression coefficients represent the mean change in the response
variable for one unit of change in the predictor variable while holding other predictors in the model constant.
The P value is based on the null hypothesis that all βs relating to an explanatory variable equal zero (no effect).
a Adjusted R2 coefficient of determination = 0.18.
b Patients’ predicted length of hospital stay is equal to 4.49 + 3.97 (PSI) + 15.58 (ARDS) + 5.20 (time to positivity <9.2 h) days. Patients’ days of length of
hospital stay increased 3.97 in case of PSI risk class IV-V, increased 15.58 in case of ARDS and increased 5.20 if time to positivity <9.2 h.
https://doi.org/10.1371/journal.pone.0182436.t003
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There were no differences in the rate of resistance to penicillin (12% vs. 9%, p = 0.73) nor
macrolides (19% vs. 14%, p = 0.28) between groups.
Discussion
A TTP of blood culture shorter than 9.2h in patients with bacteremic pneumococcal pneumo-
nia is independently associated with a more severe disease characterized by a higher C-reactive
protein level, a worst oxygenation, and more pulmonary complications which explain the
more frequent need of invasive mechanical ventilation in the early detection group. However,
we did not find an association between TTP <9.2 h and septic shock, which could be due to
the lower number of septic shock patients. In line with this, a TTP <9.2 h was independently
associated with the risk of mechanical ventilation, longer length of hospital stay, in-hospital
mortality and there was a trend towards higher 30-day mortality. These findings concord with
existing data that describe the strong association between the bacterial load and clinical out-
comes in invasive pneumococcal diseases [18,23]. These studies were performed with the poly-
merase chain reaction and showed a higher sensitivity in comparison to blood cultures,
although this method cannot measure the viability of the bacteria. Also, our results are in
accordance with the results of study by Werno et al. that reported the association of higher
pneumococcal load with increased disease severity in adults with CAP [6].
Table 4. Significant univariate and multivariate logistic regression analyses to predict in-hospital mortality.
Variable Univariate Multivariateab
OR 95% CI P Value OR 95% CI P Value
Age65 years 3.68 1.29 to 10.51 0.015 8.33 1.80 to 38.6 0.007
Alcohol consumptionb - - 0.080 - - -
No alcohol consumption 1 - - - - -
Former alcohol consumption 1.51 0.46 to 4.95 0.50 - - -
Current alcohol consumption 4.17 1.20 to 14.5 0.025 - - -
Neurological disease 3.50 1.29 to 9.47 0.014 - - -
Acute renal failure 7.29 2.35 to 22.6 0.001 4.42 1.23 to 15.97 0.023
ARDS 16.40 5.50 to 48.9 <0.001 29.98 5.52 to 162.9 0.001
Septic shock 9.70 3.56 to 26.3 <0.001 5.48 1.40 to 21.4 0.014
Mechanical ventilationd <0.001 -
Not ventilated 1 - - 1 - -
Non-invasive 7.63 2.03 to 28.6 0.003 - - -
Invasive 17.30 5.53 to 54.1 <0.001 - - -
Early detection (time to positivity <9.2 h) 3.77 1.47 to 9.70 0.006 5.35 1.55 to 18.53 0.008
Abbreviations: ARDS = acute respiratory distress syndrome; CI = confidence interval; ICU = intensive care unit; OR = odds ratio; PSI = pneumonia severity
index.
Data are shown as estimated ORs (95% CIs) of the explanatory variables in the in-hospital mortality group. The OR is defined as the probability of
membership of the group in-hospital mortality divided by the probability of membership of the non-in-hospital mortality group.
The P value is based on the null hypothesis that all ORs relating to an explanatory variable equal unity (no effect).
a Hosmer-Lemeshow goodness-of-fit test, p = 0.18.
b Predictors from the model can be used to calculate the probability of in-hospital mortality by the following formula: Exp (β)/(1+Exp(β)), where β = -6.42
+ 2.12 (in case of age65 years) + 3.40 (in case of ARDS) + 1.49 (in case of acute renal failure) + 1.70 (in case of septic shock) + 1.68 (if time to positivity
<9.2 h).
c The p-value corresponds to differences between the three groups (no alcohol consumption, former alcohol consumption or current alcohol consumption).
d The p-value corresponds to differences between the three groups (not ventilated, non-invasive or invasive).
https://doi.org/10.1371/journal.pone.0182436.t004
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Table 5. Significant univariate and multivariate logistic regression analyses to predict 30-day mortality.
Variable Univariate Multivariateab
OR 95% CI P Value OR 95% CI P Value
Age65 years 3.29 1.24 to 8.75 0.017 - - -
Chronic cardiovascular disease 2.95 0.90 to 9.64 0.074 - - -
Neurological disease 3.78 1.46 to 9.75 0.006 - - -
PSI risk class IV-V 22.13 2.93 to 167.3 0.003 19.93 2.47 to 161.1 0.005
Acute renal failure 6.25 2.22 to 17.6 0.001 - - -
ARDS 13.76 4.73 to 44.0 <0.001 11.13 2.68 to 46.2 0.001
Septic shock 8.01 3.04 to 21.10 <0.001 3.95 1.17 to 13.56 0.027
Mechanical ventilationc <0.001 -
Not ventilated 1 - - 1 - -
Non-invasive 5.88 1.64 to 21.0 0.007 - - -
Invasive 13.33 4.50 to 39.5 <0.001 - - -
Early detection (time to positivity <9.2 h) 3.05 1.23 to 7.54 0.016 2.47 0.85 to 7.21 0.097
Abbreviations: ARDS = acute respiratory distress syndrome; CI = confidence interval; ICU = intensive care unit; OR = odds ratio; PSI = pneumonia severity
index.
Data are shown as estimated ORs (95% CIs) of the explanatory variables in the 30-day mortality group. The OR is defined as the probability of membership
of the group 30-day mortality divided by the probability of membership of the non-30-day mortality group.
The P value is based on the null hypothesis that all ORs relating to an explanatory variable equal unity (no effect).
a Hosmer-Lemeshow goodness-of-fit test, p = 0.51.
b Predictors from the model can be used to calculate the probability of 30-day mortality by the following formula: Exp(β)/(1+Exp(β)), where β = -5.81 + 2.99
(in case of PSI risk class IV-V) + 2.41 (in case of ARDS) + 1.37 (in case of septic shock) + 0.91 (if time to positivity <9.2 h).
c The p-value corresponds to differences between the three groups (not ventilated, non-invasive or invasive).
https://doi.org/10.1371/journal.pone.0182436.t005
Table 6. Multivariate multinomial logistic regression analyses to predict non-invasive or invasive mechanical ventilation relative to non-
ventilated.
Variable Non-invasive mechanical ventilation Invasive mechanical ventilation
OR 95% CI P Value OR 95% CI P Value
Alcohol consumption
No alcohol consumption 1 - - 1 - -
Current alcohol consumption 2.45 0.75 to 7.94 0.14 3.14 0.99 to 9.97 0.053
Former alcohol consumption 4.84 1.24 to 18.95 0.024 3.24 0.64 to 16.49 0.16
PSI IV-V 4.83 1.52 to 15.40 0.008 2.09 0.73 to 6.02 0.17
Septic shock 3.89 1.15 to 13.17 0.029 13.99 4.75 to 41.20 0.001
Early detection (time to positivity <9.2 h) 2.25 0.83 to 6.11 0.11 4.60 1.63 to 13.03 0.004
Abbreviations: ARDS = acute respiratory distress syndrome; CI = confidence interval; OR = odds ratio; PSI = pneumonia severity index.
Data are shown as estimated ORs (95% CIs) of the explanatory variables in the non-invasive mechanical ventilation and invasive mechanical ventilation
groups. The OR is defined as the probability of membership of the groups non-invasive or invasive divided by the probability of membership of the not
ventilated group.
The P value is based on the null hypothesis that all ORs relating to an explanatory variable equal unity (no effect).
Model characteristics: likelihood ratio χ2 test, p = 0.17; R2 coefficients = 0.19 (Cox and Snell), 0.29 (Nagelkerke).
Predictors from the model can be used to calculate the probability of non-invasive mechanical ventilation or invasive mechanical ventilation by the following
formulas: Exp(β1)/(1+Exp(β1)+Exp(β2)) and Exp(β2)/(1+Exp(β1)+Exp(β2)), respectively, where β1 = -4.13 + 1.58 (in case of former alcohol consumption)
+ 0.98 (in case of current alcohol consumption) + 1.58 (in case of PSI risk class IV-V) + 1.36 (in case of septic shock) + 0.81 (if time to positivity <9.2 h) and
β2 = -4.24 + 1.18 (in case of former alcohol consumption) + 1.14 (in case of current alcohol consumption) + 0.74 (in case of PSI risk class IV-V) + 2.64 (in
case of septic shock) + 1.53 (if time to positivity <9.2 h).
https://doi.org/10.1371/journal.pone.0182436.t006
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The concept of early TTP of blood cultures is directly related with a higher bacterial con-
centration in blood. Interestingly, the first finding of our study is related to the pathogenesis of
pneumococcal infection. Patients with blood cultures with rapid growth of pneumococcus
could be due to a dysregulation in the host innate immune response, shown by the low number
of circulating leukocytes and a high inflammatory response measured by high levels of C-reac-
tive protein [23–27].
These results emphasize that the key to improve the prognosis of patients with bacteremic
pneumococcal pneumonia is to improve the host immune response against pneumococcus,
and to learn to modulate the inflammatory response of the host. A higher bacterial load could
lead to a higher inflammatory response when a β-lactam antibiotic is used [5]; this effect was
observed in meningitis and sepsis [28] and was proposed as the key for benefits of corticoste-
roids, macrolides or fluoroquinoles in adjuvant treatment of pneumonia [29–33].
TTP was better studied in child patients with bacteremic disease by several pathogens such
as S. pneumoniae, N. meningitidis and H. influenzae. A higher bacterial load in blood correlates
with severity of the disease, also the bacterial load correlates with TTP in catheter related sepsis
[34]. In paediatric patients there was no relation among TTP and severity although a positivity
correlation was described in adults with pneumococcal invasive disease [8]. A recent small
study about the relation of fluorescence rate using blood culture techniques and mortality in
patients with invasive pneumococcal pneumonia found a direct association of FR and mortal-
ity. However, the authors did not find that TTP correlated with clinical outcomes [35].
Interestingly, no statistically significant differences were observed in the use of previous
antibiotics and pneumococcal vaccine in our cohort of patients between groups. Also, there
were no differences in resistance to penicillin or macrolides.
We found that early TTP was an independent risk factor for in-hospital mortality; however,
only a trend for 30-day mortality was observed. This could be due to an under power analysis.
The prediction models we have presented are the first step in establishing more universal
models; to move forward, our prediction models will need to undergo external validations
with larger patient cohorts from multiple centers. We were able to apply internal validation
techniques to understand how likely these models will be replicable in future studies and at
other centers. Bootstrapping techniques were applied and demonstrated that the coefficients
obtained from these prediction models were quite robust. PSI was the one factor for 30-day
mortality model that the bootstrap results indicated might have limited repeatability in future
work. Removal of the PSI from the model did not change which factors were significant pre-
dictors of 30-day mortality. However, because of the clinical importance surrounding the PSI,
this variable was kept as a factor in this model despite some statistical limitations. In the real
world clinical setting where this prediction model could be used, the PSI is an important clini-
cal characteristic that can play a substantial role in decision making.
To the best of our knowledge, with the exception of one study [8] evaluating patients with
invasive pneumococcal disease, this is the first study addressing the issue of early TTP specifi-
cally in pneumococcal pneumonia in a large adult population.
TTP is an easy to obtain parameter available in all Microbiology laboratories that appears to
provide useful prognostic information, and should be reported routinely in order to help clini-
cians to identify patients at risk of worse outcome that could benefit from more aggressive
early management.
Several limitations have to be addressed. First, because the data were collected from a
single academic teaching hospital in Spain the results might not be able to be extrapolated to
other patients admitted to other types of hospitals in other countries. Second, we could only
analyze 278 patients and this sample size may result in a large type II error. Our sample size,
however, is large since this is the only study regarding this issue. Our results support the direct
Time to positivity in bacteremic pneumococcal pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0182436 August 7, 2017 15 / 18
relationship of early TTP with severe presentation and worse outcomes in patients with diag-
nosis of pneumococcal CAP.
Conclusion
In summary, we found evidence that in those patients with pneumococcal pneumonia that





The results presented have not been published elsewhere. We are indebted to all medical and
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